HIGHLIGHTS
- What: Our study contributes to a growing body of data regarding the safety of SSIA use for ICI-induced irAE treatments in advanced melanoma and NSCLC.
- Who: Sharjeel Syed and collaborators from the Division of Hematology-Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA have published the article: Studying Outcomes after Steroid-Sparing Immunosuppressive Agent vs. Steroid-Only Treatment for Immune-Related Adverse Events in Non-Small-Cell Lung Cancer (NSCLC) and Melanoma: A Retrospective Case-Control Study, in the Journal: (JOURNAL) of 11/01/2021
- How: The authors conducted a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.